Ledger.Open graph →
SEC Form D · filed November 15, 2021

Imel Biotherapeutics, Inc

Offering
$20.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Taro Inaba · Norwood, MADirectorTomer Kariv · ISFIYA, L3DirectorDori Pelled · Waltham, MAExecSilvia Noiman, Ph.D · Waltham, MAExec · DirectorTaro Inaba · Mountain View, CADirectorTomer Kariv · ISFIYA, L3DirectorDori Pelled · Waltham, MAExecSilvia Noiman, Ph.D · Waltham, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗